AGP Executive Report
Last update: 6 hours agoMeta Lawsuit: California, Colorado, Kentucky and New Jersey say Meta designed Facebook and Instagram to “addict” kids, seeking up to $1.4T in penalties in a Northern District of California filing. FDA Breakthrough (NJ biotech): Merck’s first non-injectable PCSK9 cholesterol pill, Lipfendra, won FDA approval for patients who still need LDL lowering after statins; Merck is based in Rahway. Wildfire Smoke Health: Canadian wildfire smoke pushed hazardous air across the Midwest and Northeast, with New York City and Philadelphia among the worst-hit as AirNow readings climbed. Oncology Trial (NJ): ThalassaX Therapeutics said the first U.S. patient was dosed in a Phase I trial of CS231295, a brain-penetrant Aurora B kinase inhibitor. Defense Tech (NJ): Auriga Space and the U.S. Army will test electromagnetic launchers aimed at countering drone swarms. Space Chemistry (NJ): New research on the Hillsborough meteorite reports rare “alien chemistry,” including amino acids and salty-fluid signatures, tied to early solar-system materials. Local Tech/Policy: Monroe Township’s data-center ban is now in federal court after a $300M suit by Hexa Builders. World Cup Tech Tie-In: Adidas’ Trionda Final ball uses polyurethane materials linked to Covestro’s long-running chemistry roots.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
